IIC
VRTX icon

Integrated Investment Consultants’s Vertex Pharmaceuticals VRTX Stock Holding History

Integrated Investment Consultants’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,734
Closed -$42K – 381
2024
Q3 		$42K Buy
+19,734
New +$9.48M 0.01% 315
2018
Q2 		– Sell
-151
Closed -$25K – 686
2018
Q1 		$25K Buy
+151
New +$24.7K 0.01% 518
2017
Q3 		$23K Buy
151
+28
+23% +$4.21K 0.01% 451
2017
Q2 		$16K Hold
123
– – 0.01% 485
2017
Q1 		$13K Hold
123
– – 0.01% 496
2016
Q4 		$9K Buy
123
+26
+27% +$2.12K ﹤0.01% 514
2016
Q3 		$8K Hold
97
– – ﹤0.01% 525
2016
Q2 		$8K Hold
97
– – ﹤0.01% 537
2016
Q1 		$8K Buy
+97
New +$8.77K ﹤0.01% 522

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return